Clinical Trial

Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This single-center, open-label study will evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-07-29; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2026-01-28
Trial Details
NCT Number NCT04496362
Lead Sponsor Baylor Research Institute
Conditions ECMO, Heparin, Respiratory Failure
Enrollment 100 participants
Start Date 2018-10-10
Primary Completion 2025-02-12 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-30